Boxer Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
Boxer Capital Management's ATRA Position: Q3 2024 in Review
Boxer Capital Management sold out of Atara Biotherapeutics (ATRA) in Q3 2024, closing a stake of 166,000 shares — an estimated $1.41M sold.
Boxer Capital Management first reported a position in ATRA in Q1 2024 and held it in 2 quarters. The position peaked at $2.88M in Q1 2024. 35 funds tracked by Wall St. Rank hold ATRA as of Q3 2024.
- Boxer Capital Management reported no remaining Atara Biotherapeutics position as of Q3 2024 after selling out during the quarter.
- Boxer Capital Management sold 166,000 Atara Biotherapeutics shares in Q3 2024, an estimated $1.41M.
- Boxer Capital Management first reported a position in Atara Biotherapeutics in Q1 2024 and held it in 2 quarters.
- Boxer Capital Management's Atara Biotherapeutics position peaked at $2.88M in Q1 2024.
- 35 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2024.
Based on Boxer Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.